The potential adverse effects caused by pharmaceuticals residues will be measured as changes at molecular, biochemical, cellular and physiological levels.
Transcriptomic analyses will be performed along with measurements of alterations at higher levels of biological organization such as impairment of the immune system, onset of oxidative stress, appearance of genotoxic damage, neurotoxicity, behavior changes.